Skip to main content
SpringerLink
Log in

Chronische Herzinsuffizienz

  • Chapter
Klinische Kardiologie

  • 1402 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • ACC/AHA (2001) Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult. http://www.americanheart.org url. Cited 2 Jan 2005

    Google Scholar 

  • Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821–828

    Google Scholar 

  • Al-Khadra AS, Salem DN, Rand WM et al. (1998) Antiplatelet agents and survival: A cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial. J Am Coll Cardiol 31: 419–425

    Article  PubMed  CAS  Google Scholar 

  • Allen DG, Kentish JG (1985) The cellular basis of the length-tension relation in cardiac muscle. J Mol Cell Cardiol 17: 821–840

    Article  PubMed  CAS  Google Scholar 

  • Amiodarone Trials Meta-Analysis Investigators (1997) Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in radomised trials. Lancet 350: 1417–1424

    Article  Google Scholar 

  • Anand IS, Ferrari R, Kalra GS et al. (1989) Edema of cardiac origin. Circulation 80: 299–305

    PubMed  CAS  ISI  Google Scholar 

  • Anonymus (1991) Calcium antagonist caution. Lancet 337: 885–886

    Article  Google Scholar 

  • Arai M, Matsu H, Periasamy M (1994) Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74: 555–564

    PubMed  CAS  Google Scholar 

  • Bayliss J, Norell M, Capena-Anson R et al. (1987a) Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57: 17–21

    Article  PubMed  CAS  Google Scholar 

  • Bayliss J, Thomas L, Poole-Wilson P (1987b) Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate. J Cardiovasc Pharmacol 9: 551–559

    Article  PubMed  CAS  Google Scholar 

  • Beuckelmann DJ, Erdmann E (1991) Herzinsuffizienz bei dilatativer Kardiomyopathie — Eine Störung der Calciumhomöostase. Dtsch Med Wochenschr 116: 504–508

    PubMed  CAS  Google Scholar 

  • Beuckelmann DJ, Näbauer M, Erdmann E (1991) Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol 23: 929–937

    Article  PubMed  CAS  Google Scholar 

  • Beuckelmann DJ, Näbauer M, Erdmann E (1992) Intracellular calcium handling in ventricular myocytes from patients with terminal heart failure. Circulation 85: 1046–1055

    PubMed  CAS  ISI  Google Scholar 

  • Beuckelmann DJ, Näbauer M, Erdmann E (1993) Alterations of K+-currents in isolated human ventricular myocytes from patient with terminal heart failure. Circ Res 73: 379–385

    PubMed  CAS  Google Scholar 

  • Böhm M, Pieske P, Schnabel P et al. (1989) Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved β2-adrenoceptor subpopulation. J Cardiovasc Pharmacol 14: 549–559

    Article  PubMed  Google Scholar 

  • Böhm M, Gierschik P, Jakobs KH et al. (1990b) Increase of Giα in human hearts with dilated but not ischemic cardiomyopathy. Circulation 82: 1249–1265

    PubMed  Google Scholar 

  • Böhm M, Reuschel-Janetschek E, Erdmann E (1990c) Lack of sustained hemodynamic effects of the β2-adrenoceptor agonist dopexamine in end-stage congestive heart failure. Am J Cardiol 65: 395–396

    Article  PubMed  Google Scholar 

  • Böhm M, Dorner H, Htun P et al. (1994) Effects of exercise on myocardial adenylate cyclase and Gi-expression in senescence. Am J Physiol 264: 805–814

    Google Scholar 

  • Böhm M, Zolk O, Flesch M et al. (1998) Effects of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition on cardiac β-adrenergic signal transduction. Hypertension 31: 747–754

    PubMed  Google Scholar 

  • Bonow RO, Udelson JE (1992) Left ventricular diastolic dysfunction as a cause of heart failure. Ann Intern Med 117: 502–510

    PubMed  CAS  Google Scholar 

  • Bouvagnet P, Mairhofer H, Leger JO (1989) Distribution of pattern of myosin in normal diseased human ventricular myocardium. Basic Res Cardiol 84: 91–98

    Article  PubMed  CAS  Google Scholar 

  • Bowditch HP (1871) Über die Eigentümlichkeit der Reizbarkeit, welche die Muskelfasern des Herzens zeigen. Ber Sächs Ges (Akad) Wis 652–689

    Google Scholar 

  • Brillantes AM, Allen P, Takahasi T et al. (1992) Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with endstage heart failure caused by ischemic vs. dilated cardiomyopathy. Circ Res 71: 18–26

    PubMed  CAS  Google Scholar 

  • Bristow MR, Saxon LA, Boehmer J et al. (2004) Cardiac-resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl. J Med 350: 2140–2150

    Article  PubMed  CAS  Google Scholar 

  • Brömme HJ, Holtz J (1996) Apoptosis in the heart: when and why? Mol Cell Biochem 163/164: 261–275

    Article  Google Scholar 

  • Brunkhorst D, Leyen H von der, Meyer W et al. (1989) Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea pig heart. Naunyn Schmiedebergs Arch Pharmacol 339: 575–583

    Article  PubMed  CAS  Google Scholar 

  • Burkart F, Pfisterer M, Kiowski W et al. (1990) Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel antiarrhythmic study of infarct survical (BASIS). J Am Coll Cardiol 16: 1711–1718

    PubMed  CAS  Google Scholar 

  • Burkart F, Erdmann E, Hanrath P et al. (1993) Therapie der chronischen Herzinsuffizienz. Z Kardiol 82: 200–206

    PubMed  CAS  Google Scholar 

  • Cardiac Arrhythmia Suppression Trial II Investigators (1992) Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 327: 227–233

    Google Scholar 

  • Cazeau S, Ritter P, Bakdach S et al. (1994) Four chamber pacing in dilated Cardiomyopathy. PACE 17: 1974–1979

    PubMed  CAS  ISI  Google Scholar 

  • Cheng W, Li B, Kajstura J et al. (1995) Stretch-induced programmed myocyte cell death. J Clin Invest 96: 2247–2259

    Article  PubMed  CAS  Google Scholar 

  • CIBIS Investigators and Committees (1994) A randomized trial of β-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90: 1765–1773

    Google Scholar 

  • CIBIS-II Investigators and Committees (1999) The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 353: 9–13

    Article  Google Scholar 

  • Cittadini A, Grossmann DJ, Napoli R et al. (1997) Growth hormone attenuates early ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol 29: 1109–1116

    Article  PubMed  CAS  Google Scholar 

  • Cleland JGF, Daubert J-C, Erdmann E et al. (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352: 1539–1549

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN (1990) Abnormalities of peripheral nervous system control in congestive heart failure. Circulation 82(Suppl I): 159–167

    Google Scholar 

  • Cohn JN, Levine TB, Olivari MT et al. (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819–823

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN, Archibald DG, Ziesche S et al. (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 314: 1547–1552

    PubMed  CAS  Google Scholar 

  • Cohn JN, Johnson G, Ziesche S et al. (1991) Comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325: 303–310

    PubMed  CAS  Google Scholar 

  • Consensus Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429–1435

    Google Scholar 

  • Conway MA, Allis J, Ouwerkerk R et al. (1991) Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P-magnetic resonance spectroscopy. Lancet 38: 973–976

    Article  Google Scholar 

  • Cowburn PJ, Cleland JGF, McArthur JD et al. (1998) Short-term haemodynamic effects of BQ-123, a selective endothelin ETA-receptor antagonist, in chronic heart failure. Lancet 352: 201–202

    Article  PubMed  CAS  ISI  Google Scholar 

  • Crozier I, Ikram H, Awan N et al. (1995) Losartan in heart failure, hemodynamic effects and tolerability. Circulation 91: 691–697

    PubMed  CAS  ISI  Google Scholar 

  • Cuneo RC, Wilmshurst P, Lowy C, McGauley G, Sšnksen PH (1989) Cardiac failure responding to growth hormone. Lancet: 838–839

    Google Scholar 

  • Danielsen W, Leyen H von der, Meyer W et al. (1989) Basal and isoprenaline-stimulated cAMP content in failing vs. nonfailing human cardiac preparations. J Cardiovasc Pharmacol 14: 171–173

    Article  PubMed  CAS  Google Scholar 

  • Danish Study Group on Verapamil after myocardial infarction (1990) Secondary prevention with verapamil after myocardial infarction. Am J Cardiol 66: 331–401

    Google Scholar 

  • DasGupta P, Broadhurst P, Lahiri A (1991) The effects of intravenosus carvedilol, a new multiple action vasodilatory β-blocker, in congestive heart failure. J Cardiovasc Pharmacol 18(Suppl 4): 12–16

    Google Scholar 

  • De la Bastie D, Levitsky D, Rappaport L et al. (1990) Function of the sarcoplasmic reticulum and expression of its Ca2+-ATPase-gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 66: 554–564

    PubMed  Google Scholar 

  • Demopoulos L, Yeh M, Gentilucci M et al. (1997) Nonselective β-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. Circulation 95: 1764–1767

    PubMed  CAS  ISI  Google Scholar 

  • Deswal A, Peterson NJ, Feldman AM (2001) Cytokines and cytokine receptors in advanced heart failure an analysis of the cytokine database from the Vesnarinone Trial (VEST). Circulation 103: 2055–2059

    PubMed  CAS  ISI  Google Scholar 

  • DGK (2005) Deutsche Gesellschaft für Kardiologie/Herz-und Kreislaufforschung. DGK-Leitlinien. http://www.dgk.org url. Gesehen 2 Jan 2005

    Google Scholar 

  • DiBianco R, Shabetai R, Kostuk W et al. (1989) A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 320: 677–683

    Article  PubMed  CAS  Google Scholar 

  • Dibner-Dunlap ME, Thames MD (1990) Abnormalities of baroreflex control in heart failure. Heart Failure 6: 12–16

    Google Scholar 

  • Dickstein K, Chang P, Willenheimer R et al. (1995) Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol 26: 438–445

    Article  PubMed  CAS  Google Scholar 

  • Dies F, Krell MJ, Whitlow P et al. (1986) Intermittend dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation (Suppl II): II-138

    Google Scholar 

  • Digitalis Investigation Group (1998) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336: 525–533

    Article  Google Scholar 

  • Doval HC, Nul DR, Grancelli HO et al., for Grupo de la Sobrevida en al insuficiencia Cardiaca en Argentina (GESiCA) (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 344: 493–498

    Article  PubMed  CAS  ISI  Google Scholar 

  • Drexler H (1993) Der periphere Kreislauf bei chronischer Herzinsuffizienz. Internist 34: 961–964

    PubMed  CAS  ISI  Google Scholar 

  • Drexler H, Lu W (1992) Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. Am J Physiol 262: H1640–H1645

    PubMed  CAS  Google Scholar 

  • Dubois-Randé, Merlet P, Roudot F et al. (1992) β-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy. Am Heart J 124: 679–685

    Article  PubMed  Google Scholar 

  • Duerr RL, Huang S, Miraliakbar HR et al. (1995) Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 950: 6190–6270

    Google Scholar 

  • Duerr RL, McKirnan D, Gim RD et al. (1996) Cardiovascular effects of insulin-like growth facotr-I and growth hormone in chronic left ventricular failure in the rat. Circulation 93: 2188–2196

    PubMed  CAS  ISI  Google Scholar 

  • Dupuis J, Goresky CA, Fournier A (1996) Pulmonary clearance of circulationg endothelin-1 in dogs in vivo: Exclusive role of ET(B) receptors. J Appl Physiol 81: 1510–1515

    PubMed  CAS  Google Scholar 

  • Dzau VJ, Hollenberg NK (1984) Renal response to captopril in severe heart failure: Role of furosemide in natriuresis and reversal of hyponatremia. Ann Int Med 100: 777–782

    PubMed  CAS  Google Scholar 

  • Ehsani AA, Ogawa T, Miller TR et al. (1991) Exercise training improves left ventricular systolic function in older men. Circulation 83: 96–103

    PubMed  CAS  ISI  Google Scholar 

  • Eichhorn EJ, Jeesch CM, Risser RC et al. (1990a) Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol. J Am Coll Cardiol 25: 154–162

    Article  Google Scholar 

  • Eichhorn EJ, Bedotto JM, Balloy CR et al. (1990b) Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure. Circulation 82: 473–483

    PubMed  CAS  ISI  Google Scholar 

  • Eichhorn EJ, Heesch CM, Barnett JH et al. (1994) Effect of metoprolol on function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, doubleblind, placebo-controlled study. J Am Coll Cardiol 24: 1310–1320

    PubMed  CAS  Google Scholar 

  • Elkayam U, Amin J, Mehra A et al. (1990) A prospective, randomized double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic heart failure. Circulation 82: 1954–1961

    PubMed  CAS  ISI  Google Scholar 

  • Ellbogen DA, Mohanty PK, Szentpetery S, Thames MD (1989) Arterial baroreflex abnormalities in heart failure: Reversal after orthotopic cardiac transplantation. Circulation 79: 51–58

    Google Scholar 

  • Erdmann E (1984) Therapie der akuten und chronischen Herzinsuffizienz mit Herzglykosiden. In: Riecker G (Hrsg) Handbuch der inneren Medizin. Springer, Berlin Heidelberg New York, S563–656

    Google Scholar 

  • Erdmann E, Presek P, Swozil R (1976) Über den Einfluss von Kalium auf die Bindung von Strophanthin an menschliche Herzmuskelzellmembranen. Klin Wochenschr 54: 383–389

    Article  PubMed  CAS  Google Scholar 

  • Erdmann E, Werdan K, Brown L (1985) Multiplicity of cardiac glycoside receptors in the heart. Trends Pharmacol Sci 6: 293–295

    Article  CAS  Google Scholar 

  • Eriksson H, Svärdsudd K, Larsson B et al. (1989) Risk factors for heart failure in the general population: The study of men born in 1913. Eur Heart J 10: 647–656

    PubMed  CAS  Google Scholar 

  • Eschenhagen T, Mende U, Nose M et al. (1991) Isoprenaline-induced increase in m-RNA levels of inhibitory G-protein-a-subunits in rat heart. Naunyn Schmiedebergs Arch Pharmacol 343: 609–615

    Article  PubMed  CAS  Google Scholar 

  • Eschenhagen T, Mende U, Nose M et al. (1992a) Increased messenger RNA level of the inhibitory G-protein-a-subunit-Giα2 in human endstage heart failure. Circ Res 70: 688–696

    PubMed  CAS  Google Scholar 

  • Eschenhagen T, Mende U, Schmitz W, Scholz H (1992b) Veränderungen der Genexpression bei terminaler Myokardinsuffizienz. Z Kardiol 81(Suppl 4): 33–40

    PubMed  Google Scholar 

  • Esler MD, Thompson JM, Kaye DM et al. (1995) Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation 91: 351–358

    PubMed  CAS  ISI  Google Scholar 

  • Fazio S, Cittadini A, Cuocolo A et al. (1993) J Clin Endocrinol Metab 77: 790–793

    Article  PubMed  Google Scholar 

  • Fazio S, Sabatini D, Capaldo D et al. (1996) A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 334: 809–814

    Article  PubMed  CAS  Google Scholar 

  • Feldman AM, Jackson DG, Bristow MR et al. (1991) Immunodetectable levels of the inhibitory guanine nucleotide binding regulatory proteins in failing human heart: disordance with measurements of adenylate cyclase activity and levels of pertussis toxin substrate. J Mol Cell Cardiol 23: 439–452

    Article  PubMed  CAS  Google Scholar 

  • Feldman AM, Bristow MR, Parmley WW et al., for the Vesnarinone Study Group (1993) Effects of vesnarinone on morbidity and mortality in patients with heart failure. N Engl J Med 329: 149–155

    Article  PubMed  CAS  Google Scholar 

  • Ferguson DW (1990) Baroflex-mediated circulatory control in human heart failure. Heart Failure 6: 3–11

    Google Scholar 

  • Ferguson DW, Abboud FM, Mark AL (1984) Selective impairment of baroreflex-mediated vasoconstrictor responses in patient with ventricular dysfunction. Circulation 69: 451–460

    PubMed  CAS  ISI  Google Scholar 

  • Ferguson DW, Berg J, Sanders JS (1989) Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Circulation 80: 65–77

    PubMed  CAS  ISI  Google Scholar 

  • Ferguson DW, Berg WJ, Sanders JS (1990) Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct neurographic recordings. J Am Coll Cardiol 16: 1125–1134

    PubMed  CAS  Google Scholar 

  • Flather MD, Shibata MC, Coats AJS et al. on behalf on the SENIORS Investigators (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J doi:10.1093/eurheartj/ehi 115

    Google Scholar 

  • Flesch M (2003) Pathophysiologie der akuten und chronischen Herzinsuf-fizienz — Tumornekrosefaktor. In: Erdmann E (Hrsg) Herzinsuffizienz — Ursachen, Pathophysiologie und Therapie. Wiss. Verlagsges., Stuttgart

    Google Scholar 

  • Flesch M, Schwinger RHG, Schnabel P et al. (1996) Sarcoplasmatic reticulum Ca2+TPase and phospholamban mRNA and protein levels in end-stae heart failure due to ischemic or dilated cardiomyopathy. J Mol Med 74: 321–332

    Article  PubMed  CAS  Google Scholar 

  • Flesch M, Kilter H, Cremers B et al. (1997) Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmacol Exp Ther 281: 1340–1349

    PubMed  CAS  Google Scholar 

  • Flesch M, Kilter H, Cremers B et al. (1999) Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite. J Am Coll Cardiol 33: 1062–1070

    Article  PubMed  CAS  Google Scholar 

  • Francis GS, Benedict C, Johnstone DE et al., for the SOLVD Investigators (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 82: 1724–1729

    PubMed  CAS  ISI  Google Scholar 

  • Frank O (1895) Zur Dynamik des Herzmuskels. Z Biol 32: 370–382

    Google Scholar 

  • Frustraci A, Perrone GA, Gentiloni N, Russo MA (1992) Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Pathol 97: 503–511

    Google Scholar 

  • Gauthier C, Tavernier G, Charpentier F et al. (1996) Functional β3-adrenoceptor in the human heart. J Clin Invest 98: 556–562

    Article  PubMed  CAS  Google Scholar 

  • Genth-Zotz S, Zotz R, Geil S et al. (1999) Recombinant growth hormone therapy in patients with ischemic cardiomyopathy. Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation 99: 18–21

    PubMed  CAS  ISI  Google Scholar 

  • Gheorghiade M, Hall V, Lakier JB, Goldstein S (1989) Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol 13: 134–142

    Article  PubMed  CAS  Google Scholar 

  • Gilbert EM, Anderson JL, Deitchman D et al. (1990) Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double blind, randomized study of bucindolol vs. placebo. Am J Med 88: 223–229

    Article  PubMed  CAS  Google Scholar 

  • Gilbert EM, Abraham WT, Olsen S et al. (1996) Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol vs. carvedilol in the failing heart. Circulation 94: 2817–2825

    PubMed  CAS  ISI  Google Scholar 

  • GISSI-3 (1994) Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after myocardial infarction. Lancet 343: 1115–1122

    Google Scholar 

  • Gold MR, Feliciano Z, Gottlieb SS, Fisher ML (1995) Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: A randomized study. J Am Coll Cardiol 26: 967–973

    Article  PubMed  CAS  Google Scholar 

  • Goldberg LI (1989) Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure. J Cardiovasc Pharmacol 14(Suppl 8): 21–26

    Google Scholar 

  • Goldstein RE, Boccuzzi SJ, Crues D (1991) Dilitazem increases late-onset congestive heart failure in postinfarction patients with early reductio in ejection fraction. Circulation 83: 52–60

    PubMed  CAS  ISI  Google Scholar 

  • Goodyer AVN, Jaeger CA (1955) Renal response to non-smoking hemorrhage: role of the autonomic nervous system and of the renal circulation. Am J Physiol 180: 69–74

    PubMed  CAS  Google Scholar 

  • Gottlieb SS, Dickstein K, Fleck E et al. (1993) Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation 88: 1602–1609

    PubMed  CAS  ISI  Google Scholar 

  • Gottlieb RA, Burleson KO, Kloner RA et al. (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621–1628

    Article  PubMed  CAS  Google Scholar 

  • Green SA, Cole G, Jacinto M et al. (1993) A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268: 23116–23121

    PubMed  CAS  Google Scholar 

  • Griendling KK, Murphy TJ, Alexander RW (1993) Molecular biology of the renin-angiotensin system. Circulation 87: 1816–1828

    PubMed  CAS  ISI  Google Scholar 

  • Grossman W (1990) Evaluation of systolic and diastolic function of the myocardium. In: Grossman W, Baim D (eds) Cardiac Catheterization and Angiography, 4th (edn), Lea and Febiger, Philadelphia, pp 319–342

    Google Scholar 

  • Gulati J (1992) Length-sensing function of troponin C and Starlings Law of the heart. Circulation 85: 1954–1955

    PubMed  CAS  ISI  Google Scholar 

  • Gurevitch J, Frolkis I, Yuhas Y et al. (1996) Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol 28: 247–252

    Article  PubMed  CAS  Google Scholar 

  • GUSTO Angiographic Investigators (1993) The effects of tissue plasminogen activation, streptokinase or both on coronary artery, patency, ventricular function and survival of the acut myocardial infarction. N Engl J Med 329: 1615–1622

    Article  Google Scholar 

  • Gwathmey JK, Morgan JP (1985) Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res 57: 836–843

    PubMed  CAS  Google Scholar 

  • Gwathmey JK, Slawsky MT, Hajjar RJ et al. (1990) Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest 85: 1599–1613

    Article  PubMed  CAS  Google Scholar 

  • Habib FM, Springall DR, Davies GJ et al. (1996) Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347: 1151–1155

    Article  PubMed  CAS  ISI  Google Scholar 

  • Hall AS, Murray GD, Ball SG (1997) Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE extension (AIREX) study. Lancet 349: 1493–1497

    Article  PubMed  CAS  ISI  Google Scholar 

  • Hasenfuss G (1992) Neue Kardiotonika/Inodilatatoren: Energetische Aspekte. Z Kardiol 81(Suppl 4): 57–63

    PubMed  CAS  Google Scholar 

  • Hasenfuss G, Reinecke H, Studer R et al. (1994) Relation between myocardial function and expression of sarcoplasmic reticulum Ca2t-ATPase in failing and nonfailing human myocardium. Circ Res 75: 4334–4343

    Google Scholar 

  • Hausdorfer WP, Caron MG, Lefkowitz RJ (1990) Turning off the signal. Desensitization of β-adrenergic receptor function. FASEB J 4: 2881–2889

    Google Scholar 

  • Hegglin R (1934) Über Organvolumen und Organgewicht: Nebst Bemerkungen über die Größenbestimmungsmethoden. Z Konstitutionslehre 18: 110–134

    Google Scholar 

  • Heilbrunn SM, Shah P, Bristow MR et al. (1989) Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 79: 483–490

    PubMed  CAS  ISI  Google Scholar 

  • Helin K, Stoll M, Meffert S et al. (1997) The role of angiotensin receptors in cardiovascular diseases. Annals of Medicine 29: 23–29

    Article  PubMed  CAS  ISI  Google Scholar 

  • Henderson AH (1994) Amiodarone for chronic failure. Lancet 344: 489–490

    Article  PubMed  CAS  ISI  Google Scholar 

  • Hershberger RE, Feldman AM, Bristow MR (1991) A1-Adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium. Circulation 83: 1343–1351

    PubMed  CAS  ISI  Google Scholar 

  • Heublein DM, Wie C, Lerman A et al. (1994) Endothelin in human congestive heart failure. Circulation 89: 1580–1586

    PubMed  ISI  Google Scholar 

  • Hickam JB, Cargill WH (1948) Effects of exercise pressure in normal person and in patients with cardiovascular disease and pulmonary emphysema. J Clin Invest 27: 10–15

    Article  PubMed  CAS  Google Scholar 

  • Ho KK, Anderson KM, Kannel WB et al. (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88: 107–115

    PubMed  CAS  ISI  Google Scholar 

  • Hochleitner M, Hörtnagl H, Ng CK et al. (1990) Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 66: 198–202

    Article  PubMed  CAS  Google Scholar 

  • Hoppe UC et al., Deutsche Gesellschaft für Kardiologie Herz-und Kreislaufforschung (1998) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 87: 645–661

    PubMed  CAS  Google Scholar 

  • Hulsmann WC (1991) Biochemical profile of propionyl-L-carnitine. Cardiovasc Drugs Ther 5(Suppl I): 7–10

    Article  PubMed  Google Scholar 

  • Hunkeler NM, Kullman J, Murphy AM (1991) Troponin I isoform expression in human heart. Circ Res 69: 1409–1414

    PubMed  CAS  Google Scholar 

  • Investigators of the Study on Propionyl-L-Carnitine in Chronic Heart Failure (1999) Study on propionyl-L-carnitine in chronic heart failure. Eur Heart J 19: 70–76

    Article  Google Scholar 

  • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group* (1995) ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 345: 669–685

    Article  Google Scholar 

  • Ito H, Hiroe M Hirata et al. (1993) Insulinlike growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 87: 1715–1721

    PubMed  CAS  ISI  Google Scholar 

  • Kaddoura S, Firth JD, Boheler KR, Sudgen PZH, Poole-Wilson PA (1996) Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Circulation 93: 2068–2079

    PubMed  CAS  ISI  Google Scholar 

  • Kannel WB, Cupples A (1988) Epidemiology and risk of cardiac failure. Cardiovasc Drugs Ther 2: 387–395

    Article  PubMed  Google Scholar 

  • Kannel WB, Plehn JF, Cupples A (1988) Cardiac failure an sudden death in the Framingham Study. Am Heart J 115: 869–875

    Article  PubMed  CAS  Google Scholar 

  • Kass DA (1991) Evaluation of left ventricular systolic function. Heart Failure 4: 198–205

    Google Scholar 

  • Kass DA, Baughman KL, Pak P et al. (1995) Reverse remodeling from cardiomyopasty in human heart failure. External constraint vs. active assist. Circulation 91: 2314–2318

    PubMed  CAS  ISI  Google Scholar 

  • Katz AM (1990) Cardiomyopathy of overload. N Engl J Med 322: 100–110

    PubMed  CAS  Google Scholar 

  • Kelly RA, Eid H, Kramer B et al. (1990) Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium via a pertusis toxin-sensitive pathway. J Clin Invest 86: 1164–1171

    Article  PubMed  CAS  Google Scholar 

  • Kokkonen JO, Saarinen J, Kovanen PT (1997) Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Circulation 95: 1455–1463

    PubMed  CAS  ISI  Google Scholar 

  • Konstam MA, Rousseau MF, Kronenberg MW et al. (1992) Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 86: 431–438

    PubMed  CAS  ISI  Google Scholar 

  • Krown KA, Yasui K, Brooker MJ et al. (1995) TNFα receptor expression in rat cardiac myocytes: TNFα inhibition of L-type Ca2+ current and Ca2+ transients. FEBS Lett 376: 24–30

    Article  PubMed  CAS  ISI  Google Scholar 

  • Krown KA, Page MT, Nguyen C et al. (1996) Tumor recrosis factor α-induced apoptosis in cardia myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854–2865

    Article  PubMed  CAS  Google Scholar 

  • Kubo SH, Gollub S, Bourge R et al. (1992) Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure — results of a multicenter trial. Circulation 85: 942–949

    PubMed  CAS  ISI  Google Scholar 

  • Kurabayashi M, Shibasaki Y, Komuro I et al. (1990) The myosyn switching in human cardiac hypertrophy. Jpn Circ J 54: 1192–1205

    PubMed  CAS  Google Scholar 

  • Lakatta EG (1993) Deficient Neuroendocrine Regulation of the Cardiovascular System With Advancing in Healthy Humans. Circulation 87: 631–636

    PubMed  CAS  ISI  Google Scholar 

  • Levine TB, Kalman J, Mayer L et al. (1990) Elevated circulating levels of tumor necrosis factor in congestive heart failure. N Engl J Med 323: 236–241

    PubMed  CAS  Google Scholar 

  • Levitsky D, De la Bastie D, Schwartz K, Lompré AM (1991) Ca2+-ATPase and function of sarcoplasmic reticulum during cardiac hypertrophy. Am J Physiol (Suppl) 261: 23–26

    PubMed  CAS  Google Scholar 

  • Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456–62

    Article  PubMed  CAS  Google Scholar 

  • Liggett SB, Wagoner LE, Craft LL et al. (1998) The he 164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 102: 1534–2539

    Article  PubMed  CAS  Google Scholar 

  • Linzbach AJ (1956) Über das Längenwachstum der Herzmuskelfasern und ihrer Kerne in Beziehung zur Herzdilatation. Virchows Arch (Pathol Anat) 328: 165

    Article  CAS  Google Scholar 

  • Linzbach AJ, Akuomoa-Boateng E (1973) Die Altersveränderungen des menschlichen Herzens: I Das Herzgewicht im Alter. Klin Wochenschr 51: 156–163

    Article  PubMed  CAS  Google Scholar 

  • Lompré AM, Lambert F, Lakatta EG, Schwartz K (1991a) Expression of sarcoplasmic reticulum Ca2+-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ Res 69: 1380–1388

    PubMed  Google Scholar 

  • Lompré AM, Mercadier JJ, Schwartz K (1991b) Changes in gene expression during cardiac growth. Int Rev Cytol 124: 137–186

    Article  PubMed  Google Scholar 

  • Lorell BH (1988) Left ventricular diastolic pressure-volume relations: Understanding and managing congestive heart failure. Heart Failure 4: 206–223

    Google Scholar 

  • Lowes BD, Minobe W, Abraham WT et al. (1997) Changes in gene expression in the intact human heart. Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium. Clin Invest 100: 2315–2324

    Article  CAS  Google Scholar 

  • Maciel LMZ, Polikar R, Rohrer D, Popovich BK, Dillmann WH (1990) Ageinduced decreases in the messenger RNA coding for the sarcoplasmic reticulum Ca2+-ATPase of the rat heart. Circ Res 69: 230–234

    Google Scholar 

  • Makino N, Hata T, Sugano et al. (1996) Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. J Mol Cell Cardiol 28: 507–517

    Article  PubMed  CAS  Google Scholar 

  • Mann DL (2002) Inflammatory mediators and the failing heart: past, present and the forseeable future. Cire Res 91: 988–998

    Article  CAS  Google Scholar 

  • Mann DL, Kent RI, Parsons B, Cooper G (1992) Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85: 790–804

    PubMed  CAS  ISI  Google Scholar 

  • Massie B, Bourassa M, DiBianco R et al. (1985) Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Circulation 71: 963–971

    PubMed  CAS  ISI  Google Scholar 

  • Matsumori A, Ono K, Nishio R et al. (1997) Amiodarone inhibits production of tumor necrosis factor-α-by human mononuclear cells. A possible mechanism for its effect in heart failure. Circulation 96: 1386–1389

    PubMed  CAS  ISI  Google Scholar 

  • McKnee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive failure: the Framingham Study. N Engl J Med 285: 1441–1446

    Google Scholar 

  • McMurray JJV, Ray SG, Abdulla I et al. (1992) Plasma endothelin in chronic heart failure. Circulation 85: 1374–1379

    PubMed  CAS  ISI  Google Scholar 

  • McMurray JJV (1998) Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensinconverting enzyme inhibitors? Eur Heart J 19:(Suppl I) L15–L21

    PubMed  Google Scholar 

  • Mercadier JJ, Bouveret P, Gorza L et al. (1983) Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ Res 53: 52–62

    PubMed  CAS  Google Scholar 

  • Mercadier JJ, Lompre AM, Duc P et al. (1990) Altered sacroplasmic reticulum Ca2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 85: 305–309

    Article  PubMed  CAS  Google Scholar 

  • Merit-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353: 2001–2007

    Article  Google Scholar 

  • Merola B, Cittadini A, Colao A et al. (1993) Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Matab 77: 1658–1661

    Article  CAS  Google Scholar 

  • Miller LW (1991) Mechanical assist devices in intensive cardiac care. Am Heart J 121: 1887–1892

    Article  PubMed  CAS  Google Scholar 

  • Misao J, Hayakawa Y, Ohno M et al. (1996) Expression of bcl-2 Protein, an inhibitor of apoptosis, and bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 94: 1506–1512

    PubMed  CAS  ISI  Google Scholar 

  • Molenaar P, OReilly G, Sharkey A et al. (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72: 526–538

    PubMed  CAS  Google Scholar 

  • Morgan J (1991) Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325: 626–632

    Google Scholar 

  • Morgan HE, Baker KM (1991) Cardiac hypertrophy: mechanical, neural and endocrine dependence. Circulation 83: 13–25

    PubMed  CAS  ISI  Google Scholar 

  • Movsesian MA, Colyer J, Wang JH, Krall J (1990) Phospholamban-mediated stimulation of Ca2+-uptake in sarcoplasmic reticulum from normal and failing hearts. J Clin Invest 85: 1698–1702

    Article  PubMed  CAS  Google Scholar 

  • Movsesian MA, Smith CJ, Krall et al. (1991) Sarcoplasmatic reticulum-associated cyclic adenosine 5’-monophosphate phosphodiesterase activity in normal and failing human hearts. J Clin Invest 88: 15–19

    Article  PubMed  CAS  Google Scholar 

  • MRC Working Party (1992) Medical Research Council trial of treatment of hypertension in older adults: principal results. BMI 304: 405–412

    Google Scholar 

  • Mulieri LA, Hasenfuss G, Leavitt B et al. (1992) Altered myocardial force-frequency relation in human heart failure. Circulation 85: 1743–1750

    PubMed  CAS  ISI  Google Scholar 

  • Müller FU, Boheler KR, Eschenhagen T et al. (1993) Isoprenaline stimulates gene transcription of the inhibitory G protein: a-subunit Gia2 in rat heart. Circ Res 72: 696–700

    PubMed  Google Scholar 

  • Münzel T, Giaid A, Kurz S et al. (1995a) Evidence for a role of endothelin 1 and protein kinase C in nitroglyarine tolerance. Proc Natl Acad Sci 92: 5244–5248

    Article  PubMed  Google Scholar 

  • Münzel T, Sayegh H, Freeman BA et al. (1995b) Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross tolerance. J Clin Invest 95: 187–194

    Article  PubMed  Google Scholar 

  • Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233–236

    Article  PubMed  CAS  ISI  Google Scholar 

  • Murphy TH Takeuchi K, Alexander RW (1992) Molecular cloning of AT 1 angiotensin receptors. Am J Hyperten 5: 236–242

    Google Scholar 

  • Näbauer M, Beuckelmann DJ, Erdmann E (1993) Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 73: 386–394

    PubMed  Google Scholar 

  • Narula J, Haider N, Virmani R et al. (1996) Apoptosis in myocytes in endstage heart failure. N Engl J Med 335: 1182–1189

    Article  PubMed  CAS  Google Scholar 

  • NETWORK Investigators (1998) Clinical outcome with enalapril in symptomatic chronic heart faillure; a dose comparison. Eur Heart J 19: 481–489

    Article  CAS  Google Scholar 

  • Nickenig G, Böhm M (1998a) Cardiac specific expression of AT1 receptors in experimental heart failure. Heart Failure Reviews 3: 101–107

    Article  CAS  Google Scholar 

  • Nickenig G, Bšhm M (1998b) Vaskuläre AT1-Rezeptoren bei arterieller Hypertonie und metabolischem Syndrom. Herz Kreisl 30: 329–334

    ISI  Google Scholar 

  • Nul DR, Doval HC, Grancelli HO et al., for the GESICA-GEMA Investigators (1997) Heart rate is a marker of amiodarone mortality reduction in severe heart failure. J Am Coll Cardiol 29: 1199–1205

    Article  PubMed  CAS  Google Scholar 

  • Ogawa T, Spina RJ, Martin III WH et al. (1992) Effects of aging, sex, and physical training on cardiovascular responses to exercixe. Circulation 86: 494–503

    PubMed  CAS  ISI  Google Scholar 

  • Ohlsson Å, Beck R, Bennett T et al. (1995) Monitoring of mixed venous oxygen saturation and pressure from biosensors in the right ventricle. A 24 hour study in patients with heart failure. Eur Heart J 16: 1215–1222

    PubMed  CAS  Google Scholar 

  • Olivetti G, Melissari M, Capasso JM, Anversa P (1991) Cardiomyopathy of the aging human heart. Myocyte loss and reactice cellular hypertrophy. Circ Res 68: 1560–1568

    PubMed  CAS  Google Scholar 

  • Olivetti G, Abbi R, Quaini F et al. (1997) Apoptosis in the failing human heart. N Engl J Med 336/16: 1131–1141

    Article  Google Scholar 

  • Olsen SL, Gilbert EM, Renlund DG et al. (1995) Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study. J Am Coll Cardiol 25: 1225–1231

    Article  PubMed  CAS  Google Scholar 

  • Oral H, Dorn GW, Mann DL (1997) Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 272: 3836–4842

    Google Scholar 

  • Osterziel KJ, Strohm O, Schuler J et al. (1998) Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351: 1233–1237

    Article  PubMed  CAS  ISI  Google Scholar 

  • Otsu K, Willard HF, Khanna VK et al. (1990) Cloning of cDNA encoding the Ca2+-release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem 265: 13472–13483

    PubMed  CAS  Google Scholar 

  • Packer M (1989) Pathophysiological mechanismus underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure. Circulation 80(Suppl IV): IV-59–IV-67

    CAS  Google Scholar 

  • Packer M (1992) Pathophysiology of chronic heart failure. Lancet 340: 88

    Article  PubMed  CAS  ISI  Google Scholar 

  • Packer M, Cohn JN (1999) Concensus recommendations forthe management of chronic heart failure. Am J Cardiol 83(Suppl): 1A–38A

    Article  Google Scholar 

  • Packer M, Carver JR, Rodeheffer RJ et al. (1991) Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 325: 1468

    Article  PubMed  CAS  Google Scholar 

  • Packer M for the RADIANCE-Study (1993) Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 329: 1–7

    Article  PubMed  CAS  Google Scholar 

  • Packer M, Bristow MR, Cohn JN et al. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1348–1355

    Article  Google Scholar 

  • Packer M, Caspi A, Charlton V et al. (1998) Arteriosclerosis, thrombosis and vascular biology, basic science/circulation, cardiopulmonary and critical care, high blood pressure research, kidney: Hormonal, metabolic and immunologic modulation in heart failure. Circulation 98:(Suppl1) 3

    ISI  Google Scholar 

  • Petrou M, Clarke S, Morrison K et al. (1999) Clenbuterol increases stroke power and contractile speed of skeletal muscle for cardia assist. Circulation 99: 713–729

    PubMed  CAS  ISI  Google Scholar 

  • Pfeffer MA, Braunwald E, Moyé LA et al. (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327: 669–677

    Article  PubMed  CAS  Google Scholar 

  • Pfister R, Scholz M, Wielckens K et al. (2004) Use of NT-proBNP in routine testing and comprarison to BNP. Eur J Heart Fail 6: 289–293

    Article  PubMed  CAS  Google Scholar 

  • Pfisterer ME, Kiowski W, Burckhardt D et al. (1992) Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Am J Cardiol 69: 1399–1402

    Article  PubMed  CAS  Google Scholar 

  • Philbin EF (1998) Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting. Clin Cardiol 21: 103–108

    Article  PubMed  CAS  Google Scholar 

  • Pieske B, Beyermann B, Breu V et al. (1999) Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 99: 1802–1809

    PubMed  CAS  ISI  Google Scholar 

  • Pitt B, Segal R, Martinez FA et al., on behalf of ELITE Study Investigators (1997) Randomised trial of losartan vs. captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349: 747–752

    Article  PubMed  CAS  ISI  Google Scholar 

  • Pönicke K, Vogelsang M, Heinroth M et al. (1998) Endothelin-receptors in the failing and non-failing human heart. Circulation 97: 744–751

    PubMed  Google Scholar 

  • Port JD, Gilbert EM, Larrabee P (1990) Neurotransmitter depletion compromises the ability of indirect acting amines to provide inotropic support in the failing human heart. Circulation 81: 929–938

    PubMed  CAS  ISI  Google Scholar 

  • Pousset F, Isnard R, Lechat P et al. (1998) Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 18: 254–258

    Google Scholar 

  • Pratt CM, Camm JA, Cooper W et al., for the SWORD Investgators (1998) Mortality in the survival with oral D-Sotalol (SWORD) trial: Why did patients die? Am J Cardial 81: 869–876

    Article  CAS  Google Scholar 

  • publication Committee for the VMAC Investigators (2002) Vasodilatation in the Management of Acute CHF. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287: 1531–1540

    Google Scholar 

  • RALES Investigators (1996) Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure [the randomized aldactone evaluation study (RALES)]. Am J Cardiol 78: 902–907

    Article  Google Scholar 

  • Rasmussen PR, Minobe W, Bristow MR (1990) Calcium antagonist binding sites in failing and non failing ventricular myocardium. Biochem Pharmacol 39: 691–696

    Article  PubMed  CAS  Google Scholar 

  • Rathore SS, Curtis JP, Wang Y et al. (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289: 871–878

    Article  PubMed  CAS  ISI  Google Scholar 

  • Raya T, Fonken SJ, Lee RW et al. (1991) Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure. Am J Hypertens 4: 334–340

    Google Scholar 

  • Reichman RT, Joyo CI, Dembitsky WP et al. (1990) Improved patient survival after cardiac arrest using a cardiopulmonary support system. Ann Thorac Surg 49: 101–105

    Article  PubMed  CAS  Google Scholar 

  • Reinecke H, Studer R, Eschenhagen T et al. (1993) Erhöhte Genexpression des kardialen Na+/Ca2+-Austauschers im insuffizienten menschlichen Myokard. Z Kardiol 82(Suppl): 20

    Google Scholar 

  • Remes J, Reunanen A, Aromaa A, Pyörälä K (1992) Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J 13: 588–593

    PubMed  CAS  Google Scholar 

  • Reynolds DW, Bartelt N, Taephe R, Bennett TD (1995) Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol 25: 1176–1182

    Article  PubMed  CAS  Google Scholar 

  • Rowles JR, Mortimer BJ, Olsen DB (1993) Ventricular assist and total artificial heart devices for clinical use in 1993. ASAIO J 39: 840–855

    Article  PubMed  CAS  Google Scholar 

  • Sadoshima J, Xu Y, Slayter HS, Izumo S (1993) Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977–984

    Article  PubMed  CAS  ISI  Google Scholar 

  • Sakai M, Danzinger RS, Xiao RP et al. (1992) Contractile response of individual cardiac myocytes to norepinephrine declines with senescence. Am J Physiol 262: H184–H189

    PubMed  CAS  Google Scholar 

  • Sasaki K, Yamano Y, Bardhan S et al. (1991) Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II typ-1 receptor. Nature 351: 230–232

    Article  PubMed  CAS  ISI  Google Scholar 

  • Sasse S, Brand NJ, Kyprianou P et al. (1993) Troponin-I-gene expression during human cardiac development and in end-stage heart failure. Circ Res 72: 932–938

    PubMed  CAS  Google Scholar 

  • Satoh M, Nakamura M, Tamura G et al. (1997) Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 29: 716–724

    Article  PubMed  CAS  Google Scholar 

  • Schieffer B, Wirger A, Meybrunn M et al. (1994) Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89: 2273–2282

    PubMed  CAS  ISI  Google Scholar 

  • Schmitz W, Leyen H von der, Meyer W et al. (1989) Phosphodiesterase inhibition and positive inotropic effects. J Cardiovasc Pharmacol 14(Suppl 3): 11–14

    Google Scholar 

  • Schnabel P, Mies F, Böhm M (1999) Hormontherapie bei Herzinsuffizienz: Wachstumshormon und Insulin-like-growth factor-I. Z Kardiol 88: 1–9

    Article  PubMed  CAS  Google Scholar 

  • Schunkert H, Dzau VJ, Tang SS et al. (1990) Increased rat cardiac angiotensin converting enzyme activity and m-RNA expression in pressure overload left ventricular hypertrophy: Effects on coronary restistance, contractility, and relaxation. J Clin Invest 86: 1913–1923

    Article  PubMed  CAS  Google Scholar 

  • Schwartz K, Beckmann J, Dufour C et al. (1992) Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several french families. Circ Res 71: 3–8

    PubMed  CAS  Google Scholar 

  • Schwinger RHG, Böhm M, Erdmann E (1990) Evidence against spare or uncoupled β-adrenoceptors in the human heart. Am Heart J 119:899

    Google Scholar 

  • Schwinger RHG, Böhm M, Mittmann C et al. (1991) Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium. J Mol Cell Cardiol 23: 461–471

    Article  PubMed  CAS  Google Scholar 

  • Schwinger RHG, Böhm M, Erdmann E (1992) Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. Am Heart J 123: 116–128

    Article  PubMed  CAS  Google Scholar 

  • Schwinger RHG, Böhm M, Müller-Ehmsen J et al. (1993) Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart. Circulation 88: 2267–2276

    PubMed  CAS  ISI  Google Scholar 

  • Sharow VG, Sabbah HN, Shimoyama H et al. (1996) Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 148: 141–1149

    Google Scholar 

  • SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in Elderly Program (SHEP). JAMA 265: 3255–3264

    Article  Google Scholar 

  • Sheu SS, Blaustein MP (1986) Sodium/calcium exchange and regulation of cell calcium and contractility in cardiac muscle, with a note about vascular smooth muscle. In: Fozzard HA (ed) The heart and cardiovascular system. Raven, New York, pp 509–535

    Google Scholar 

  • Simonton CA, Daly PA, Kereiakes D, Modin G, Chatterjee K (1987) Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents. Chest 92: 118–124

    Article  PubMed  CAS  ISI  Google Scholar 

  • Singh SN, Fletcher RD, Fisher S et al., for the Survival Trial of Antiarrhythmic in Congestive Heart Failure (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 333: 77–82

    Article  PubMed  CAS  Google Scholar 

  • Solomon SD, Jarcho JA, McKenna W et al. (1990) Familiar hypertrophic cardiomyopathy is a genetically heterogenous disease. J Clin Invest 86: 993–999

    Article  PubMed  CAS  Google Scholar 

  • SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293–302

    Google Scholar 

  • SOLVD Investigators (1992) Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685–691

    Google Scholar 

  • Spann JF, Buccino RA, Sonnenblick EH, Braunwaldt E (1967) Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ Res 21: 341–349

    PubMed  Google Scholar 

  • Starling EH (1908) The Linacre lecture on the law of the heart. Longmans, London

    Google Scholar 

  • Starling EH (1921) The law of the heart. Lancet I: 212

    Article  Google Scholar 

  • Steimle AE, Stevenson LW, Chelimsky-Fallick C et al. (1997) Sustained hemodynamic efficacy of therapy tailored to reduced filling pressures in survivors with advanced heart failure. Circulation 96: 1165

    PubMed  CAS  ISI  Google Scholar 

  • Steinfath M, Geertz B, Schmitz W et al. (1991) Distinct downregulation of cardiac β1-and β2-adrenoceptors in different human heart disease. Naunyn Schmiedebergs Arch Pharmacol 343: 217–220

    Article  PubMed  CAS  Google Scholar 

  • STOP-Hypertension: Dahlöf B Lindholm LH Hansson et al. (1991) Morbidity and mortality in the swedish trial in older patients with hypertension. Lancet 338: 1281–1285

    Article  PubMed  Google Scholar 

  • Studer R, Reinecke H, Müller B, Holtz J, Just H, Drexler H (1994) Increased Angiotensin-I converting enzyme gene expression in the failing human heart. J Clin Invest 94: 301Ð310

    Article  Google Scholar 

  • Sung CP, Arleth AJ, Ohlstein EH (1993) Carvedilol inhibits vascular smooth muscle cell proliferation. J Cardiovasc Pharm 21: 221–227

    CAS  Google Scholar 

  • Suzuki T, Kumazaki T, Mitsiu Y (1993) Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 193: 823–830

    Article  Google Scholar 

  • Swedberg K, Hjalmarson A, Waagstein F, Wallentin I (1979) Prolongation of survival in congestive cardiomyopathy by β-receptor blockade. Lancet I: 1374–1376

    Article  Google Scholar 

  • Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group (1990) Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 82: 1730–1736

    PubMed  CAS  ISI  Google Scholar 

  • Swedberg K, Held P, Kjekshus J et al., on behalf of the CONSENSUS II Study Group (1992) Effects of the early administration enalapril on mortality in patients with acute myocardial infarction. N Engl J Med 327: 678–684

    Article  PubMed  CAS  Google Scholar 

  • Takahashi T, Allen P, Lacro R et al. (1992) Expression of dihydropyridine receptor (Ca2+-channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 90: 927–935

    Article  PubMed  CAS  Google Scholar 

  • Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT (1991) Cardiac myocyte necrosis induced by angiotensin II. Circ Res 1185–1195

    Google Scholar 

  • Tate CA, Taffet GE, Hudson EK et al. (1990) Enhanced calcium uptake of cardiac sarcoplasmic reticulum in exercise-trained old rats. Am J Physiol 258: H431–H435

    PubMed  CAS  Google Scholar 

  • Thomas PB, Eck Liu, Webb M et al. (1996) Evidence of the endothelin-1 autocrine loop in cardiac myocytes: relation to contractile function with congestive heart failure. Am J Physiol 40: H2629–H2673

    Google Scholar 

  • Timmermann PBMWM, Wong PC, Chiu AT et al. (1993) Angiotensin II receptors and angiotensin II receptors antagonists. Pharmacol Rev 45: 205–251

    Google Scholar 

  • Timsit J, Riou B, Bertherat J et al. (1990) Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest 86: 507–515

    Article  PubMed  CAS  Google Scholar 

  • Torre-Amione G, Kapadia S, Lee J et al. (1995) Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92: 1487–1493

    PubMed  CAS  Google Scholar 

  • Torre-Amione G, Kapadia S, Lee J et al. (1996) Tumor necrosis factor-α and tumor necrosis factor receptors in the faiing human heart. Circulation 93: 704–711

    PubMed  CAS  Google Scholar 

  • Ullrich KJ, Riecker G, Kramer K (1954) Das Druckvolumendiagramm des Warmblüterherzens. Pflugers Arch 259: 481–489

    Article  PubMed  CAS  ISI  Google Scholar 

  • Unverferth DV, Blanford M, Kates RE, Leier CV (1980) Tolerance to dobutamine after a 72-hour continuous infusion. Am J Med 69: 262–266

    Article  PubMed  CAS  Google Scholar 

  • Urata H, Nishimura H, Ganten D (1995) Mechanisms of angiotensin II formation in humans. Eur Heart J 16: 79–85

    PubMed  CAS  Google Scholar 

  • Uretsky BF, Jessup M, Konstam MA et al. (1990) Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Circulation 82: 774–780

    PubMed  CAS  ISI  Google Scholar 

  • Uretsky BF, Young JB, Eden F et al., on behalf of the PROVED Investigate Group (1993) Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED Trial. J Am Coll Cardiol 22: 955–962

    PubMed  CAS  Google Scholar 

  • Van Veldhuisen D, Man A, Dunselman P et al., on behalf of the DIMT Study Group (1993) Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: Results of the Dutch ibopamine multicenter trial (DIMT). J Am Coll Cardiol 22: 1564–1573

    PubMed  Google Scholar 

  • Vantrimpont P, Rouleau JL, Wun CC et al. (1997) Additive beneficial effects of β-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement (SAVE) study. J Am Coll, Cardiol 29: 229–236

    Article  CAS  Google Scholar 

  • Varonkov Y, Shell WE, Smirnov V et al. (1977) Augmentation of serum CPK activity by digitalis in patients with acute myocardial infarction. Circulation 55: 719–727

    PubMed  CAS  ISI  Google Scholar 

  • Volterrani M, Desenzani P, Lorusso R et al. (1997) Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet 349: 1067–1068

    Article  PubMed  CAS  ISI  Google Scholar 

  • Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I (1975) Effect of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37: 1022–1036

    Article  PubMed  CAS  Google Scholar 

  • Waagstein F, Caidahl K, Wallentin I et al. (1989) Long-term β-blockade in dilated cardiomyopathy: effects of short-and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 80: 551–563

    PubMed  CAS  ISI  Google Scholar 

  • Waagstein F, Bristow MR, Swedberg K et al. (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342: 1441–1446

    Article  PubMed  CAS  ISI  Google Scholar 

  • Wang TJ, Larson MG, Levy D, et al. (2004) Plasma natriuretic peptid levels and the risk of cardiovascular events and death. N Engl J Med 350: 655–663

    Article  PubMed  CAS  Google Scholar 

  • Wankerl M, Böhm M, Morano I et al. (1990) Calcium sensitivity and myosin light chain pattern of atrial and ventricular skinned fibers from patients with various kinds of cardiac disease. J Mol Cell Cardiol 22: 1425–1438

    Article  PubMed  CAS  Google Scholar 

  • Weber KT, Brilla CG (1992) Left ventricular hypertrophy and structural remodeling as a determinant of myocardial failure. In: Cruickshank JM, Messerli FH (eds) Left ventricular hypertrophy and its regression. Science, London, pp 21–29

    Google Scholar 

  • WHO (1995) Physician guidelines (for GPS) designed to be translated and distributed worldwide to primary care physicans.

    Google Scholar 

  • Wikstrand J, Kendall M (1992) The role of b receptor blockade in preventing sudden death. Eur Heart J 13: 111–120

    PubMed  Google Scholar 

  • Wilson JR, Mancini DM (1993) Skeletal muscle metabolic dysfunction — implications for exercise intolerance in heart failure. Circulation 82(Suppl VII): 104–109

    Google Scholar 

  • Wilson JR, Reichek JR, Dunkman WB, Goldberg S (1981) Effect of diuresis on the performance of the failing left ventricle in man. Am J Med 70: 234–239

    Article  PubMed  CAS  Google Scholar 

  • Woodley SL, Gilbert EM, Anderson JL et al. (1991) β-blockade with bucindolol in heart failure caused by ischemic vs. idiopathic dilated cardiomyopathy. Circulation 84: 2426–2441

    PubMed  CAS  ISI  Google Scholar 

  • Xamoterol in severe heart failure study group (1990) Xamoterol severe heart failure. Lancet 336: 1–6

    Article  Google Scholar 

  • Xiao RP, Spurgeon HA, O’Connor F, Lakatta EG (1994) Age-associated changes in β-adrenergic modulation on rat cardiac excitation-contraction coupling. J Clin Invest 94: 2051–2059

    Article  PubMed  CAS  Google Scholar 

  • Xu D, Emoto N, Giaid A et al. (1994) ECE-1: A membrane bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473–485

    Article  PubMed  CAS  ISI  Google Scholar 

  • Yamada H, Fabris B, Allen AM (1991) Localization of angiotensin converting enzyme in rat heart. Circ Res 68: 141–151

    PubMed  CAS  Google Scholar 

  • Yonezawa T, Umemoto S, Fujii A et al. (1996) Comparative effects of type 1 angiotensin II-receptor blockade with angiotensin-converting-enzyme inhibitor of left ventricular distensibility and collagen metabolism in spontaneously hypertensive rats. J Cardiovasc Pharmacol 27: 119–124

    Article  PubMed  CAS  Google Scholar 

  • Yue TL, McKenna PJ, Gu JL et al. (1993) Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells. Hypertension 22: 922–928

    PubMed  CAS  ISI  Google Scholar 

  • Yue TL, McKenna PG, Gu JL et al. (1994) Carvedilol, a new vasodilatating β-adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils. Cardiovasc Res 28: 400–406

    Article  PubMed  CAS  Google Scholar 

  • Zierhut W, Stude R, Laurent D et al. (1996) Left ventricular wall stress and sarcoplasmic reticulum Ca2+-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade. Cardiovasc Res 31: 758–768

    Article  PubMed  CAS  Google Scholar 

  • Zolk O, Quattek MS, Sitzler G et al. (1999) Expression of endothelin-1, endothelin converting enzyme, and endothelin-receptors in chronic heart failure. Circulation 99: 2218–2123

    Google Scholar 

  • Zucker IH, Wang W, Chen JS (1990) Baroreceptor and cardiac receptor abnormalities in experimental heart failure. Heart Failure 6: 33–41

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik III für Innere Medizin, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Germany

    E. Erdmann

Authors
  1. E. Erdmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik III für Innere Medizin, Klinikum der Universität zu Köln, Kerpener Str. 62, 50937, Köln, Germany

    Erland Erdmann

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Erdmann, E. (2006). Chronische Herzinsuffizienz. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29425-2_5

Download citation

  • DOI: https://doi.org/10.1007/3-540-29425-2_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23742-6

  • Online ISBN: 978-3-540-29425-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation